Cargando…
Current Updates on the Management of AL Amyloidosis
Systemic immunoglobulin light chain (AL) amyloidosis is a rare but fatal disease. It results from clonal proliferation of plasma cells with excessive production of insoluble misfolded proteins that aggregate in the extracellular matrix, causing damage to the normal architecture and function of vario...
Autores principales: | Elsayed, Marwa, Usher, Sara, Habib, Muhammad Hamza, Ahmed, Nausheen, Ali, Jawad, Begemann, Madeline, Shabbir, Syed Ahmed, Shune, Leila, Al-Hilli, Jaffar, Cossor, Furha, Sperry, Brett W., Raza, Shahzad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425803/ https://www.ncbi.nlm.nih.gov/pubmed/34527111 http://dx.doi.org/10.14740/jh866 |
Ejemplares similares
-
Vasovagal Syncope and Pulseless Electrical Activity Cardiac Arrest in Patients With Immunoglobulin Light Chain Cardiac Amyloidosis: A Case Series
por: Sperry, Brett W, et al.
Publicado: (2023) -
Recognizing acute promyelocytic leukemia in a patient with treated chronic lymphocytic leukemia
por: Nanua, Suparna, et al.
Publicado: (2020) -
Ocular complications of antineoplastic therapies
por: Bader, Abbas, et al.
Publicado: (2023) -
A Unique Case of Relapsed B-Acute Lymphoblastic Leukemia/Lymphoma as an Isolated Omental Mass
por: Kantekure, Kanchan, et al.
Publicado: (2014) -
Incidence and Evaluation of Incidental Abnormal Bone Marrow Signal on Magnetic Resonance Imaging
por: Shah, Gunjan L., et al.
Publicado: (2014)